Drug Use Investigation for Toviaz

Pfizer

Status: Completed

Conditions: Overactive Bladder (OAB)

Treatments: Drug: Fesoterodine (Toviaz)

Study type: Observational

Funder types: Industry

Identifiers

NCT01936870

A0221096

Details and patient eligibility

About

The purpose of this study is to collect effectiveness and safety information of fesoterodine related to their appropriate use in daily practice.

Enrollment: 2,521 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients prescribed fesoterodine (Toviaz).

Exclusion criteria

• There are no exclustion criteria

Trial design

2,521 participants in 1 patient group

Fesoterodine (Toviaz)

Treatment:

Drug: Fesoterodine (Toviaz)